Special Situation

105 tickers in this investment thesis
Ranks this page's recent reports by score.
ABIVAX Société Anonyme
ABVX·Healthcare
D ★Strong Sell
Current$91.06
Sep 27, 2026

Abivax's Phase 3-validated obefazimod and long cash runway create a credible UC launch path, but its pre-revenue valuation, binary FDA risk, and heavy dilution leave little margin for execution error.

Score
57
Bullish
BLSH·Technology
D ★Strong Sell
Current$38.34
Sep 19, 2026

Bullish has a credible institutional crypto and tokenization growth engine, but premium valuation, heavy share dilution and the $4.2B Equiniti integration burden leave insufficient risk-adjusted upside at $38.34.

Score
51
GameStop Corp.
GME·Consumer Discretionary
D ★Strong Sell
Current$21.81
Sep 15, 2026

GameStop has delivered a striking profitability turnaround and owns a valuable eBay stake, but shrinking core revenue, dilution and concentrated capital-allocation risk leave the case too dependent on management and outside assets.

Score
54
MiniMed Group, Inc.
MMED·Healthcare
F Avoid
Current$22.50
Sep 14, 2026

MiniMed has a credible diabetes-technology growth engine led by Flex, CGM attachment and a strong pipeline, but negative free cash flow, low current returns and an expensive forward multiple make the post-spin risk-reward unattractive today.

Score
44
Copart, Inc.
CPRT·Industrials
B ★★★Hold
Current$29.95
Target$37.95
Return+26.7%
Sep 13, 2026

Copart combines a high-ROIC global vehicle-auction moat and aggressive share repurchases with a historically compressed valuation, but stalled U.S. growth, margin pressure, and the $1.9B ACV integration create a meaningful execution hurdle.

Score
71
IREN Limited
IREN·Financials
A ★★★★Buy
Current$35.45
Target$76.13
Return+114.7%
Aug 30, 2026

IREN's integrated AI infrastructure and gigawatt-scale power assets offer undervalued exposure to hyperscaler demand, but its vast data center construction pipeline brings high volatility and execution risk.

Score
93
ReNew Energy Global Plc
RNW·Utilities
B ★★★Hold
Current$6.81
Target$7.02
Return+3.1%
Aug 26, 2026

ReNew is poised for a definitive take-private buyout at $7.02 per share, offering a low-risk merger arbitrage play, though investors must monitor regulatory and shareholder approval hurdles before the March 2027 deadline.

Score
75
Hawaiian Electric Industries, Inc.
HE·Utilities
F Avoid
Current$11.50
Aug 25, 2026

Hawaiian Electric offers a distressed deep-value multiple driven by the fallout of the Maui wildfire crisis, but investors must remain hyper-vigilant regarding ongoing cash burn, massive debt burdens, and severe regulatory headwinds that threaten further equity dilution.

Score
38
Ducommun Incorporated
DCO·Industrials
F Avoid
Current$191.65
Aug 25, 2026

Ducommun offers compelling exposure to the defense munitions cycle, but material weaknesses in accounting controls, rising inventory bloat and an extreme valuation that assumes flawless execution create hard-to-quantify downside risk.

Score
19
LCI Industries
LCII·Consumer Discretionary
B ★★★Hold
Current$101.98
Target$123.83
Return+21.4%
Aug 25, 2026

LCI Industries is a brilliantly managed, cash-flowing tollbooth for the RV industry trading at a cyclical discount, but its near-term upside is entirely capped by the arbitrage math of its pending, regulator-scrutinized merger with Patrick Industries.

Score
84
Trump Media & Technology Group Corp.
Current$9.10
Aug 24, 2026

Trump Media functions as a highly capitalized but operationally dysfunctional holding vehicle, artificially bolstered by a $1.9 billion digital asset treasury but fatally compromised by extreme overvaluation, catastrophic cash burn, and a looming $1 billion convertible debt dilution cliff.

Score
14
Kyndryl Holdings, Inc.
KD·Technology
F Avoid
Current$12.55
Aug 24, 2026

Kyndryl presents a deceptively cheap optical valuation driven by rapid growth in its AI-consulting segment, but an active SEC investigation into material accounting weaknesses and a catastrophic cash burn profile make the stock an uninvestable value trap.

Score
23